Placental transfer of SR49059 in the human dually perfused cotyledon in vitro

Placenta

Volumn 22, Issue 10, 2001, Pages 870-875

  Lagrange, F J ^a   Brun, J L ^b   Clot, P F ^c   Leng, J J ^b   Saux, M C ^a   Kieffer, G ^c   Bannwarth, B G ^a,d  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b HÔPITAL PELLEGRIN   (France)

^c SANOFI   (France)

^d Jefferson Health System   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHENAZONE; RELCOVAPTAN; RITODRINE; UTERUS SPASMOLYTIC AGENT; VASOPRESSIN RECEPTOR; VASOPRESSIN RECEPTOR ANTAGONIST;

ARTICLE; CONTROLLED STUDY; DELIVERY; DRUG CLEARANCE; FETUS; FETUS CIRCULATION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PASSIVE TRANSPORT; PLACENTA PERFUSION; PLACENTAL TRANSFER; PREGNANCY; PRIORITY JOURNAL; STEADY STATE; TRANSPORT KINETICS; ULTRAVIOLET RADIATION;

EID: 0035217679     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1053/plac.2001.0731     Document Type: Article

References (31)

1. Trans-placental transfer of four anti-inflammatory agents. A study carried out by in vitro perfusion
2. (S)-ketoprofen accumulation in premature neonates with renal failure who were exposed to the racemate during pregnancy
3. Models for placental transfer studies of drugs
4. Determination of SR 49059 in human plasma and urine by LC-APCI/MS/MS
5. Modèle d'étude in vitro du passage des médicaments
6. Criteria for evaluating perfusion experiments and presentation of results
7. Repeated oral ascending doses tolerability study of SR49059 (t.i.d) in healthy male and female subjects
8. Effects of pH on antipyrine transfer across the human placenta ex vivo
9. Maternal and fetal plasma concentrations of ritodrine
10. A risk-benefit assessment of therapies for premature labour
11. Human placental transfer of the prostaglandin inhibitor sulindac using an in vitro model
12. The significance of plasma protein binding on the fetal/maternal distribution of drugs at steady-state
13. Passage of S(+)- and R(-)-ketoprofen across the human isolated perfused placenta
14. Placental transfer of sulindac, sulindac sulfide, and indomethacin in a human placental perfusion model
15. Pharmacokinetic changes during pregnancy and their clinical relevance
16. Vasopressin V2 (SR121463A) and V1a (SR49059) receptor antagonists both inhibit desmopressin vasorelaxing activity
17. Human placental transport of oxytocin
18. Transfer of ritodrine and norepinephrine in human placenta: In vitro study
19. Transfer of Salbutamol in the human placenta in vitro
20. Valproic acid in the perinatal period: Decreased maternal serum protein binding results in fetal accumulation and neonatal displacement of the drug and some metabolites
21. Effect of ritodrine hydrochloride on fetal perfusion pressure in dually perfused human placenta
22. Mechanisms underlying arginine vasopressin-induced relaxation in monkey isolated coronary arteries
23. Une nouvelle technique de perfusion de l'espace intervilleux dans le placenta isolé
24. Techniques to study human placental transport
25. The roles of the cyclo-oxygenases types one and two in prostaglandin biosynthesis in human fetal membranes at term
26. Placental oxygen consumption. Part II: In vitro studies
27. Transfer across the perfused human placenta of antipyrine, sodium and leucine
28. Analytical methods validation: Bioavailability, bioequivalence, and pharmacokinetics studies
29. Transplacental transfer of beta-adrenergic drugs studied by an in vitro perfusion method of an isolated human placental lobule
30. Effects of the nonpeptide V(1) vasopressin receptor antagonist SR49059 in hypertensive patients
31. Placental passage of the oxytocin antagonist atosiban